Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2019, Vol. 24 ›› Issue (5): 561-566.doi: 10.12092/j.issn.1009-2501.2019.05.013

Previous Articles     Next Articles

Analysis of the efficacy, safety and economics of prophylactic antibiotics in high-risk neonates guided by C reaction protein and procalcitonin

HUA Xudan, XIE Hongyi, YU Shufang   

  1. Department of Pediatrics, Cixi Maternal and Child Health Hospital, Cixi 315300, Zhejiang, China
  • Received:2018-10-15 Revised:2018-12-12 Online:2019-05-26 Published:2019-05-28

Abstract:

AIM: To evaluate the efficacy, safety and economics of C reaction protein (CRP) and procalcitonin (PCT) in the prevention of the use of antibiotics in high-risk newborns.  METHODS:One hundred and twenty-four cases of high risk neonates treated in our hospital from July 2015 to January 2018 were selected as the research subjects and were divided into the control group (62 cases) and the experimental group (62 cases) by random digital tables. The children in the control group were treated with prophylactic antibiotic treatment. The experimental group was treated with selective antibiotics according to the level of CRP and PCT. The positive rate of bacterial culture, the incidence of sepsis and the incidence of adverse reactions were compared between the two groups. RESULTS:There was no statistical difference between the levels of CRP and PCT and the positive rate in the two groups (t/χ2=0.299, -0.461, 0.292, 0.544, 0.186, P=0.766, 0.646, 0.589, 0.461, 0.666). There was no statistical difference in the positive rates of bacteria culture before and after treatment in the two groups (χ2=0.040, 0.287, P=0.842, 0.592), and the positive rate of bacteria culture in the two groups was significantly lower than that before treatment (χ2=47.825, 40.367, P=0.000, 0.000), and the incidence of sepsis in two groups was 12.90% and 14.52%, respectively, which have no statistical significance (χ2=0.068, P=0.794). The NICU treatment in the experimental group was significantly lower than that in the control group (t=2.904, 2.729, 2.152, 5.337, P=0.004, 0.007, 0.033, 0.000), and there was no statistical difference between the two groups (χ2=0.372, P=0.542). The incidence of adverse reactions in the control group was 19.35%, which was significantly higher than that in the experimental group (6.46%, χ2=4.593, P=0.032). CONCLUSION:The effect of preventive use of antibiotics under the guidance of CRP and PCT in high-risk newborns show similar efficay of universal application, which can significantly reduce treatment time and treatment costs, obviously reduce treatment-related adverse reactions and improve the short-term prognosis.

Key words: high-risk newborns, antibiotics, C-reactive protein, procalcitonin, safety

CLC Number: